Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
With consistent use, your skin appears brighter, smoother, and more refreshed
However, the company faces intensifying competition from Eli Lilly's tirzepatide (Mounjaro, Zepbound), which has demonstrated superior weight loss efficacy, reshaping prescriber preferences in obesity management [2]
There are sequalae to weight loss that might not be beneficial. Ozempic babies and the role of contraception Although weight loss associated with GLP-1s may improve pregnancy odds for some women, studies suggest that certain GLP-1s can also interfere with birth control, leading to an unexpected pregnancy during a time when clinicians recommend pregnancy be avoided
Eli Lillys rival GLP-1 and GIP receptor agonist, tirzepatide (Zepbound), recorded an extraordinary $517 million in US sales in the first quarter of 2024, in the first full quarter after being approved by the FDA in November
